C
Catherine Charbonnel
Researcher at Alenia Aeronautica
Publications - 51
Citations - 2317
Catherine Charbonnel is an academic researcher from Alenia Aeronautica. The author has contributed to research in topics: Multiple myeloma & Fault detection and isolation. The author has an hindex of 17, co-authored 49 publications receiving 2179 citations. Previous affiliations of Catherine Charbonnel include University of Nantes & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome
Hervé Avet-Loiseau,Michel Attal,Philippe Moreau,Catherine Charbonnel,Frédéric Garban,Cyrille Hulin,Serge Leyvraz,Mauricette Michallet,Ibrahim Yakoub-Agha,Laurent Garderet,Gerald Marit,Lucienne Michaux,Laurent Voillat,Marc Renaud,Bernard Grosbois,Gaelle Guillerm,Lotfi Benboubker,Mathieu Monconduit,Catherine Thieblemont,Philippe Casassus,Denis Caillot,Anne-Marie Stoppa,Jean-Jacques Sotto,Marc Wetterwald,Charles Dumontet,Jean-Gabriel Fuzibet,Isabelle Azais,Véronique Dorvaux,Marc Zandecki,Régis Bataille,Stephane Minvielle,Jean-Luc Harousseau,Thierry Facon,Claire Mathiot +33 more
TL;DR: In myeloma, the genomic aberrations t(4;14) and del(17p), together with beta2-microglobulin level, are important independent predictors of survival and have implications for the design of risk-adapted treatment strategies.
Journal ArticleDOI
Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome
Olivier Decaux,Laurence Lodé,Florence Magrangeas,Catherine Charbonnel,Wilfried Gouraud,Pascal Jézéquel,Michel Attal,Jean-Luc Harousseau,Philippe Moreau,Régis Bataille,Loïc Campion,Hervé Avet-Loiseau,Stephane Minvielle +12 more
TL;DR: Gene expression-based survival prediction and molecular features associated with high-risk patients may be useful for developing prognostic markers and may provide basis to treat these patients with new targeted antimitotics.
Journal ArticleDOI
Prognostic Significance of Copy-Number Alterations in Multiple Myeloma
Hervé Avet-Loiseau,Cheng Li,Florence Magrangeas,Wilfried Gouraud,Catherine Charbonnel,Jean-Luc Harousseau,Michel Attal,Gerald Marit,Claire Mathiot,Thierry Facon,Philippe Moreau,Kenneth C. Anderson,Loïc Campion,Nikhil C. Munshi,Stephane Minvielle +14 more
TL;DR: A genome-wide analysis of malignant plasma cells from 192 newly diagnosed patients with myeloma using high-density, single-nucleotide polymorphism (SNP) arrays to identify genetic lesions associated with prognosis demonstrated the power and accessibility of molecular karyotyping to predict outcome in myel cancer.
Journal ArticleDOI
Achievement of at Least Very Good Partial Response Is a Simple and Robust Prognostic Factor in Patients With Multiple Myeloma Treated With High-Dose Therapy: Long-Term Analysis of the IFM 99-02 and 99-04 Trials
Jean-Luc Harousseau,Hervé Avet-Loiseau,Michel Attal,Catherine Charbonnel,Frédéric Garban,Cyrille Hulin,Mauricette Michallet,Thierry Facon,Laurent Garderet,Gerald Marit,Nicolas Ketterer,Thierry Lamy,Laurent Voillat,François Guilhot,Chantal Doyen,Claire Mathiot,Philippe Moreau +16 more
TL;DR: In the context of ASCT, achievement of at least VGPR is a simple prognostic factor that has importance in intermediate and high-risk MM and can be informative in more patients than CR.
Journal ArticleDOI
Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
Gabriel Ricolleau,Catherine Charbonnel,Laurence Lodé,Delphine Loussouarn,Marie-Pierre Joalland,Ralf Bogumil,Sabine Jourdain,Stephane Minvielle,Mario Campone,Régine Deporte-Fety,Loïc Campion,Pascal Jézéquel +11 more
TL;DR: SELDI‐TOF‐MS protein profiling clearly showed that a high level of cytosolic ubiquitin and/or a low level of FLC were associated with a good prognosis in breast cancer.